Literature DB >> 16311700

[Recurrent Impetigo Herpetiformis: successfully managed with ciclosporine. Report of one case].

Enrique Valdés1, Tatiana Núñez, Daniel Pedraza, Hernán Muñoz.   

Abstract

Impetigo Herpetiformis is a high-risk gestational skin disease that represents a risk for both the mother and offspring. Its management is based on multisystemic support and maternal steroid therapy. When these measures are insufficient to control the disease, the association of ciclosporine to the treatment has been proposed. We report a 24 year-old woman with a 16 weeks pregnancy, that presented with Impetigo Herpetiformis. The disease was refractory to the use of steroids, the patient had a metabolic decompensation and a dehydration with electrolyte imbalance. Therefore, treatment with ciclosporine was initiated and a rapid regression of the lesions was observed. Gestation was maintained, with a good perinatal outcome.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16311700     DOI: 10.4067/s0034-98872005000900011

Source DB:  PubMed          Journal:  Rev Med Chil        ISSN: 0034-9887            Impact factor:   0.553


  2 in total

1.  Recurrent impetigo herpetiformis with diabetes and hypoalbuminemia successfully treated with cyclosporine, albumin, insulin and metformin.

Authors:  Chembolli Lakshmi; C R Srinivas; Sarah Paul; T V Chitra; K Kanchanamalai; L S Somasundaram
Journal:  Indian J Dermatol       Date:  2010 Apr-Jun       Impact factor: 1.494

2.  Cyclosporine in the management of impetigo herpetiformis: a case report and review of the literature.

Authors:  Aikaterini Patsatsi; Theodoros D Theodoridis; Dimitrios Vavilis; Vasilios Tzevelekis; Aikaterini Kyriakou; Dimitrios Kalabalikis; Dimitrios Sotiriadis
Journal:  Case Rep Dermatol       Date:  2013-03-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.